Strategic Partnerships TIBBIYAH operates as a diversified healthcare holding with multiple arms including full ownership of FMS and Premma, plus a significant 50-50 Philips Healthcare Saudi Arabia JV, indicating strong capacity to collaborate on large-scale turnkey projects and innovative clinical solutions that can be upsell to Saudi healthcare providers.

Genomics Capability Partnership with Beijing Genomics Institute to launch GenAlive Genomics Laboratory positions TIBBIYAH as a gateway for advanced genomic testing and personalized medicine services, presenting cross-sell opportunities to hospitals seeking genomic diagnostics and data-driven care.

Growth Through M&A Recent acquisition of Alhammadmedical and the company’s IPO history suggest an active growth strategy and appetite for expanding service lines and capacity, creating sales opportunities in integrated medical equipment, service contracts, and turnkey project delivery for larger hospital networks.

Leadership Transformation New leadership appointments as of 2026, including a new Chairman and CEO, signal a strategic shift and potential focus areas such as transformation programs, efficiency improvements, and expanded market reach—opening doors for executive-led conversations around modernization and capital expenditure.

Saudi Market Penetration With a long track record of delivering mega healthcare projects in KSA and a strong local footprint, TIBBIYAH is well-positioned to pursue large-scale procurement, integrated systems deployment, and maintenance partnerships with public and private healthcare providers seeking comprehensive solution ecosystems.